Omeros Market Cap 2009-2019 | OMER

Omeros market cap history and chart from 2009 to 2019. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Omeros market cap as of March 30, 2020 is $0.6B.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.602B $0.112B
Omeros Corporation is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. Omeros' most clinically advanced product candidates are derived from its proprietary PharmacoSurgery(TM) platform designed to improve clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological and other surgical and medical procedures. Omeros has four ongoing PharmacoSurgery(TM) clinical development programs, and its lead product candidate, OMS103HP, is being evaluated in Phase 3 clinical trials for use during arthroscopic surgery to improve postoperative joint function and reduce postoperative pain. Omeros is also building a diverse pipeline of preclinical programs targeting inflammation and central nervous system disorders.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $131.482B 23.01
Medtronic (MDT) Ireland $120.468B 16.20
Stryker (SYK) United States $59.680B 19.28
Boston Scientific (BSX) United States $42.738B 19.25
Baxter (BAX) United States $40.475B 0.00
Coloplast (CLPBY) Denmark $29.624B 45.72
Lonza Group Ag (LZAGY) Switzerland $29.586B 0.00
Terumo (TRUMY) Japan $24.707B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $24.477B 0.00
ResMed (RMD) United States $20.528B 35.67
Zimmer Biomet Holdings (ZBH) United States $19.596B 12.06
Smith & Nephew SNATS (SNN) United Kingdom $15.397B 0.00
Sunny Optical Technology (SNPTF) China $15.257B 0.00
Insulet (PODD) United States $11.048B 675.96
Bio-Rad Laboratories (BIO) United States $9.648B 45.09
William Demant Holdings (WILYY) Denmark $7.898B 0.00
DiaSorin S.p.A (DSRLF) Italy $6.714B 0.00
Hill-Rom Holdings (HRC) United States $6.668B 19.18
Perrigo (PRGO) Ireland $6.275B 11.44
GN STORE NORD (GNNDY) Denmark $5.486B 0.00
Canopy Growth (CGC) Canada $5.097B 0.00
Haemonetics (HAE) United States $5.078B 31.25
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
Quidel (QDEL) United States $3.950B 34.67
ICU Medical (ICUI) United States $3.899B 25.46
Neogen (NEOG) United States $3.088B 52.31
GW Pharmaceuticals (GWPH) United Kingdom $2.652B 0.00
NuVasive (NUVA) United States $2.447B 18.92
Agios Pharmaceuticals (AGIO) United States $2.403B 0.00
Envista Holdings (NVST) United States $2.359B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.316B 0.00
National Vision Holdings (EYE) United States $1.599B 26.93
AtriCure (ATRC) United States $1.227B 0.00
Aurora Cannabis (ACB) Canada $1.204B 0.00
Cardiovascular Systems (CSII) United States $1.197B 0.00
TG Therapeutics (TGTX) United States $1.075B 0.00
NanoString Technologies (NSTG) United States $0.879B 0.00
Aphria (APHA) $0.879B 0.00
Phibro Animal Health (PAHC) United States $0.820B 16.21
VAREX IMAGING (VREX) United States $0.770B 15.99
InMode (INMD) Israel $0.705B 0.00
Cerus (CERS) United States $0.702B 0.00
DFB Healthcare Acquisitions (AHCO) United States $0.642B 0.00
PetIQ (PETQ) United States $0.606B 16.50
Eagle Pharmaceuticals (EGRX) United States $0.549B 32.63
OraSure Technologies (OSUR) United States $0.504B 62.54
Quanterix (QTRX) United States $0.482B 0.00
Lantheus Holdings (LNTH) United States $0.481B 10.82
LeMaitre Vascular (LMAT) United States $0.458B 25.80
Surmodics (SRDX) United States $0.455B 52.34
Vapotherm (VAPO) United States $0.364B 0.00
Organigram Holdings (OGI) Canada $0.363B 0.00
Owens & Minor (OMI) United States $0.347B 9.50
Zynex (ZYXI) United States $0.338B 36.79
HEXO (HEXO) $0.310B 0.00
Meridian Bioscience (VIVO) United States $0.301B 12.12
Utah Medical Products (UTMD) United States $0.292B 20.88
Repro-Med Systems (KRMD) United States $0.291B 183.00
MacroGenics (MGNX) United States $0.286B 0.00
Female Health (VERU) United States $0.214B 0.00
Cytosorbents (CTSO) United States $0.212B 0.00
BioLife Solutions (BLFS) United States $0.192B 117.38
Exagen (XGN) United States $0.165B 0.00
Viemed Healthcare (VMD) United States $0.162B 18.30
Rockwell Medical (RMTI) United States $0.151B 0.00
United Health Products (UEEC) United States $0.148B 0.00
Evolus (EOLS) United States $0.139B 0.00
Bovie Medical (APYX) United States $0.124B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.124B 0.00
Liberty Health Sciences (LHSIF) Canada $0.110B 0.00
Chembio Diagnostics (CEMI) United States $0.099B 0.00
Fonar (FONR) United States $0.093B 6.76
Chimerix (CMRX) United States $0.092B 0.00
Brainsway (BWAY) Israel $0.072B 0.00
MTech Acquisition (KERN) United States $0.069B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.069B 0.00
United-Guardian (UG) United States $0.061B 12.86
Nephros (NEPH) United States $0.059B 0.00
Wound Management Technologies (SMTI) United States $0.054B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.052B 0.00
Surface Oncology (SURF) United States $0.051B 0.00
GUARDION HEALTH (GHSI) United States $0.034B 0.00
ImmuCell (ICCC) United States $0.032B 0.00
FSD PHARMA INC (HUGE) Canada $0.027B 0.00
NF Energy Saving (BIMI) China $0.023B 0.00
Trinity Biotech (TRIB) Ireland $0.019B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.010B 0.00
Capricor Therapeutics (CAPR) United States $0.005B 0.00
Senestech (SNES) United States $0.004B 0.00
NeuroMetrix (NURO) United States $0.002B 0.00
Akers Biosciences Inc (AKER) United States $0.001B 0.00